Erasca (ERAS) Current Assets (2020 - 2026)
Erasca (ERAS) posted Current Assets of $253.8 million for Q1 2026, down 11.34% on a QoQ basis from $286.2 million in Q4 2025, and down 19.34% year-over-year from $314.6 million in Q1 2025.
Erasca (ERAS) Current Assets (2020 - 2026) Analysis & Trends
Erasca's Current Assets history runs 7 years deep, the most recent figure standing at $253.8 million for Q1 2026.
- Quarterly Current Assets fell 19.34% year-over-year to $253.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.8 million (down 19.34% YoY) and the FY2025 annual result came in at $286.2 million, down 7.3% from the prior year.
- Current Assets was $253.8 million for Q1 2026 at Erasca, down from $286.2 million in the prior quarter.
- Across five years, Current Assets topped out at $444.5 million in Q4 2022 and bottomed at $253.8 million in Q1 2026.
- A 5-year average of $339.5 million and a median of $320.7 million in 2023 frame the typical range for Current Assets.
- Annual changes were most pronounced in 2022 — Current Assets soared 93.33% — and 2023, when it declined 27.86%.
- Erasca's Current Assets stood at $444.5 million in 2022, then retreated by 27.86% to $320.7 million in 2023, then fell by 3.71% to $308.8 million in 2024, then slipped by 7.3% to $286.2 million in 2025, then decreased by 11.34% to $253.8 million in 2026.
- Business Quant data shows ERAS's Current Assets at $253.8 million in Q1 2026, $286.2 million in Q4 2025, and $299.9 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 289.93 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 73.04 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 6.60 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 35.73 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 11.73 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 18.21 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 521.86 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 8.07 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 1.97 Bn |
| 10 | Erasca | 5.89 Bn | 5.89 Bn | - | 253.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.78 Mn |
| Dec 31, 2025 | 286.24 Mn |
| Sep 30, 2025 | 299.93 Mn |
| Jun 30, 2025 | 310.66 Mn |
| Mar 31, 2025 | 314.62 Mn |
| Dec 31, 2024 | 308.79 Mn |
| Sep 30, 2024 | 330.17 Mn |
| Jun 30, 2024 | 418.01 Mn |
| Mar 31, 2024 | 306.62 Mn |
| Dec 31, 2023 | 320.68 Mn |
| Sep 30, 2023 | 305.97 Mn |
| Jun 30, 2023 | 323.85 Mn |
| Mar 31, 2023 | 397.88 Mn |
| Dec 31, 2022 | 444.50 Mn |
| Sep 30, 2022 | 365.75 Mn |
| Jun 30, 2022 | 381.42 Mn |
| Mar 31, 2022 | 403.37 Mn |
| Dec 31, 2021 | 420.02 Mn |
| Sep 30, 2021 | 492.31 Mn |
| Jun 30, 2021 | 197.29 Mn |